Can you get a flu shot immediately after a Cosentyx dose?
Yes, it's generally safe to receive an inactivated flu vaccine right after a Cosentyx (secukinumab) injection. Cosentyx suppresses parts of the immune system by blocking IL-17A, which mainly affects T-cell responses rather than broad antibody production needed for inactivated vaccines like the standard flu shot. Clinical guidelines and real-world data show no increased infection risk or reduced vaccine effectiveness from timing them close together.[1][2]
What do official guidelines say about live vs. inactivated vaccines with Cosentyx?
Inactivated vaccines, including the flu shot, annual COVID-19 shots, and pneumococcal vaccines, are recommended even during Cosentyx treatment—ideally given before the next dose if possible, but safe anytime. Live vaccines (e.g., nasal flu spray, shingles vaccine) are avoided due to infection risk from weakened immunity. The CDC and Novartis (Cosentyx manufacturer) align on this: proceed with inactivated flu shots per schedule.[1][3]
Does Cosentyx weaken the flu shot's protection?
Studies indicate Cosentyx causes minimal impact on antibody responses to inactivated flu vaccines. A 2020 trial in psoriasis patients on secukinumab found comparable seroprotection rates to healthy controls (over 90% for key flu strains). Immune suppression is targeted, preserving humoral immunity for vaccines.[2][4]
What if you're on other immunosuppressants with Cosentyx?
Combining Cosentyx with drugs like methotrexate, steroids, or JAK inhibitors heightens overall immunosuppression. Still, inactivated flu shots remain advised—discuss with your doctor for personalized timing, as response might be slightly blunted.[1][5]
When should you talk to your doctor before the flu shot?
Consult if you have active infections, recent live vaccines, or uncontrolled conditions like diabetes. Monitor for standard flu shot side effects (soreness, mild fever), which aren't amplified by Cosentyx. No specific washout period exists post-Cosentyx.[3]
[1]: Novartis Cosentyx Prescribing Information
[2]: Journal of the American Academy of Dermatology - Vaccine Response in IL-17 Inhibitors (2020)
[3]: CDC Guidelines on Immunization for Immunocompromised Adults
[4]: Clinical Infectious Diseases - Secukinumab and Influenza Vaccination (2021)
[5]: American College of Rheumatology Vaccine Recommendations